Kevin Bitterman Net Worth & Insider Trades
Kevin Bitterman - Director, Akero Therapeutics, Inc
What is Kevin Bitterman's Net Worth?
The current estimated net worth of Akero Therapeutics, Inc's Director, Kevin Bitterman, is estimated to be about $56.14M . Kevin Bitterman owns about 268,722 units of Akero Therapeutics, Inc common stock. In the last 2 years at Akero Therapeutics, Inc, Kevin Bitterman has sold an estimated value of $835.7K worth.
What is Kevin Bitterman's Past Insider Trading?
Kevin Bitterman's largest purchase order was 3,974,858 units , worth over $4.32M on June 25, 2019. Kevin Bitterman's largest sale order was 17,489 units , worth over $459.61K on June 3, 2021. In total, Kevin Bitterman has made about 6 transactions over 2 years of their time at Akero Therapeutics, Inc. Kevin Bitterman usually trades in June, with the busiest year in 2021, 2020 and 2019.
Kevin Bitterman
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Kevin Bitterman's' Mailing Address?
- Mailing address is C/o Polaris Venture Partners 1000 Winter Street, Suite 3350 Waltham MA 02451 MA
What are Akero Therapeutics, Inc's Past Insider Trades?
Akero Therapeutics, Inc's most recent insider trade came on June 5, 2023 by Andrew Cheng who sold 25,000 units worth $1.13M . In the last 4 years, insiders at Akero Therapeutics, Inc have sold an estimated value of $153.1M and bought an estimated value of $100.07M worth of shares. Insider trading is most common in December, with the busiest year in 2022. The most active traders at the company are Andrew Cheng, President and CEO, Jonathan Young, Chief Operating Officer, and Richard William White, Chief Financial Officer .
Akero Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||